← Back to Clinical Trials
Recruiting NCT03983291
FaReWell Depression - Facial Exercise Program to Treat Depression
Trial Parameters
Condition Depression
Sponsor Zentrum für Angst und Depressionsbehandlung Zürich
Study Type INTERVENTIONAL
Phase N/A
Enrollment 40
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2019-06-01
Completion 2025-03-01
Interventions
FaReWell Depression
Brief Summary
This study investigates if a physiotherapeutic exercise program designed to relax facial muscles associated with the expression of negative emotions and to activate and strengthen facial muscles associated with the expression of positive emotions can reduce the symptoms of depression and improve wellbeing and quality of life in the affected patients.
Eligibility Criteria
Inclusion Criteria: * Mild to moderate unipolar depression * Stable treatment for at least 6 weeks Exclusion Criteria: * Organic mental disorders * Mental disorders due to psychoactive substance use * Schizophrenia and other psychotic disorders * Previous cosmetic procedures (botulinum toxin, fillers, lifting) * Facial palsy * Facial skin disorders